Long-Term Hearing Outcome For Vestibular Schwannomas After Microsurgery And Radiotherapy: A Systematic Review and Meta-Analysis.
acoustic neuroma
hearing loss
hearing preservation
meta‐analysis
microsurgery
radiosurgery
stereotactic radiotherapy
systematic review
vestibular schwannoma
Journal
Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery
ISSN: 1097-6817
Titre abrégé: Otolaryngol Head Neck Surg
Pays: England
ID NLM: 8508176
Informations de publication
Date de publication:
24 Jul 2024
24 Jul 2024
Historique:
revised:
27
06
2024
received:
08
03
2024
accepted:
06
07
2024
medline:
24
7
2024
pubmed:
24
7
2024
entrez:
24
7
2024
Statut:
aheadofprint
Résumé
Hearing loss is a common symptom associated with vestibular schwannoma (VS), either because of the tumor's effects on the cochlear nerve or due to active treatments such as surgery or stereotactic radiosurgery (SRS). Treatment decisions for VS are based on factors including tumor size, hearing status, patient symptoms, and institutional preference. The study aimed to investigate long-term auditory outcomes in VS patients undergoing active treatments with a hearing preservation intent. A systematic literature review was conducted following Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, searching Scopus, Pubmed, and Web of Science databases from inception to January 2024. Studies meeting inclusion criteria, including a minimum 5-year follow-up and assessment of pre- and posttreatment hearing outcomes, were included. Pooled prevalence estimates for serviceable hearing after SRS and microsurgery were calculated using MetaXL software. Risk of bias assessment was performed with the Risk of Bias in Non-randomized Studies of Interventions tool. Nine studies met the inclusion criteria, with 356 patients included for analysis. The pooled prevalence of maintaining serviceable hearing after SRS at 10 years was 18.1% (95% confidence interval [CI]: 1.7%-43.3%), with wide prediction intervals indicating variability in outcomes. Microsurgery demonstrated a higher prevalence of maintaining long-term serviceable hearing, with a pooled estimate of 74.5% (95% CI: 63.5%-84.1%). This systematic review underscores the importance of long-term follow-up in evaluating auditory outcomes in VS treatment. Despite the biases inherent to pretreatment patients selection, hearing preservation microsurgery for sporadic VS removal demonstrated favorable and stable long-term serviceable hearing.
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024 The Author(s). Otolaryngology–Head and Neck Surgery published by Wiley Periodicals LLC on behalf of American Academy of Otolaryngology–Head and Neck Surgery Foundation.
Références
Marinelli JP, Beeler CJ, Carlson ML, Caye‐Thomasen P, Spear SA, Erbele ID. Global incidence of sporadic vestibular schwannoma: a systematic review. Otolaryngol Head Neck Surg. 2022;167(2):209‐214. doi:10.1177/01945998211042006
Reznitsky M, Petersen MMBS, West N, Stangerup SE, Cayé‐Thomasen P. Epidemiology of vestibular schwannomas—prospective 40‐year data from an unselected national cohort. Clin Epidemiol. 2019;11:981‐986. doi:10.2147/CLEP.S218670
Gupta VK, Thakker A, Gupta KK. Vestibular schwannoma: what we know and where we are heading. Head Neck Pathol. 2020;14(4):1058‐1066. doi:10.1007/s12105-020-01155-x
Carlson ML, Link MJ. Vestibular schwannomas. N Engl J Med. 2021;384(14):1335‐1348. doi:10.1056/NEJMra2020394
Eggink MC, Frijns JHM, Sagers JE, O'Malley JT, Liberman MC, Stankovic KM. Human vestibular schwannoma reduces density of auditory nerve fibers in the osseous spiral lamina. Hear Res. 2022;418:108458. doi:10.1016/j.heares.2022.108458
Cazzador D, Astolfi L, Daloiso A, et al. Tumor microenvironment in sporadic vestibular schwannoma: a systematic, narrative review. Int J Mol Sci. 2023;24(7):6522. doi:10.3390/ijms24076522
Sagers JE, Sahin MI, Moon I, et al. NLRP3 inflammasome activation in human vestibular schwannoma: implications for tumor‐induced hearing loss. Hear Res. 2019;381:107770. doi:10.1016/j.heares.2019.07.007
Zanoletti E, Mazzoni A, d'Avella D. Hearing preservation in small acoustic neuroma: observation or active therapy? literature review and institutional experience. Acta Neurochir. 2019;161(1):79‐83. doi:10.1007/s00701-018-3739-x
Zanoletti E, Mazzoni A, Frigo AC, Borsetto D, Cazzador D. Hearing preservation outcomes and prognostic factors in acoustic neuroma surgery: predicting cutoffs. Otol Neurotol. 2020;41(5):686‐693. doi:10.1097/MAO.0000000000002602
Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;29:n71. doi:10.1136/bmj.n71
Gardner G, Robertson JH. Hearing preservation in unilateral acoustic neuroma surgery. Ann Otol Rhinol Laryngol. 1988;97(1):55‐66. doi:10.1177/000348948809700110
Committee on Hearing and Equilibrium. Committee on Hearing and Equilibrium guidelines for the evaluation of hearing preservation in acoustic neuroma (vestibular schwannoma)∗. Otolaryngol Head Neck Surg. 1995;113(3):179‐180. doi:10.1016/S0194-5998(95)70101-X
NHLBI NIH. Study quality assessment tools. July, 2021. https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools
Sterne JA, Hernán MA, Reeves BC, et al. ROBINS‐I: a tool for assessing risk of bias in non‐randomised studies of interventions. BMJ. 2016;355:i4919. doi:10.1136/bmj.i4919
Doi SAR, Barendregt JJ. Meta‐analysis I: Computational methods. In: Doi SAR, Williams GM, eds. Methods of Clinical Epidemiology. Springer Series on Epidemiology and Public Health. Springer Berlin Heidelberg; 2013:229‐252. doi:10.1007/978-3-642-37131-8_14
Barendregt JJ, Doi SA, Lee YY, Norman RE, Vos T. Meta‐analysis of prevalence. J Epidemiol Community Health. 2013;67(11):974‐978. doi:10.1136/jech-2013-203104
Normand SLT. Meta‐analysis: formulating, evaluating, combining, and reporting. Stat Med. 1999;18(3):321‐359. doi:10.1002/(SICI)1097-0258(19990215)18:3<321::AID-SIM28>3.0.CO;2-P
Borenstein M. Avoiding common mistakes in meta‐analysis: Understanding the distinct roles of Q, I‐squared, tau‐squared, and the prediction interval in reporting heterogeneity. Res Synth Methods. 2023;15:jrsm.1678. doi:10.1002/jrsm.1678
Borenstein M. How to understand and report heterogeneity in a meta‐analysis: The difference between I‐squared and prediction intervals. Integr Med Res. 2023;12(4):101014. doi:10.1016/j.imr.2023.101014
Migliavaca CB, Stein C, Colpani V, et al. Meta‐analysis of prevalence: I2 statistic and how to deal with heterogeneity. Res Synth Methods. 2022;13(3):363‐367. doi:10.1002/jrsm.1547
Comprehensive Meta‐Analysis. Prediction intervals program. January 13, 2024. www.meta-analysis.com
Furuya‐Kanamori L, Barendregt JJ, Doi SAR. A new improved graphical and quantitative method for detecting bias in meta‐analysis. Int J Evid Based Healthc. 2018;16(4):195‐203. doi:10.1097/XEB.0000000000000141
Roos DE, Potter AE, Brophy BP. Stereotactic radiosurgery for acoustic neuromas: what happens long term. Int J Radiat Oncol Biol Phys. 2012;82(4):1352‐1355. doi:10.1016/j.ijrobp.2011.04.068
Carlson ML, Jacob JT, Pollock BE, et al. Long‐term hearing outcomes following stereotactic radiosurgery for vestibular schwannoma: patterns of hearing loss and variables influencing audiometric decline. J Neurosurg. 2013;118(3):579‐587. doi:10.3171/2012.9.JNS12919
Maksimoski M, Bajaj A, Giri S, Sharpe LM, Kalapurakal J, Micco AG. Long‐term hearing outcomes from gamma knife treatment for vestibulocochlear nerve schwannomas in a large, tertiary care, academic hospital. Otol Neurotol. 2021;42(10):1553‐1559. doi:10.1097/MAO.0000000000003305
Friedman RA, Kesser B, Brackmann DE, Fisher LM, Slattery WH, Hitselberger WE. Long‐term hearing preservation after middle fossa removal of vestibular schwannoma. Otolaryngol Head Neck Surg. 2003;129(6):660‐665. doi:10.1016/j.otohns.2003.08.002
Woodson EA, Dempewolf RD, Gubbels SP, et al. Long‐term hearing preservation after microsurgical excision of vestibular schwannoma. Otol Neurotol. 2010;31(7):1144‐1152. doi:10.1097/MAO.0b013e3181edb8b2
Mazzoni A, Zanoletti E, Calabrese V. Hearing preservation surgery in acoustic neuroma: long‐term results. Acta Otorhinolaryngol Ital. 2012;32(2):98‐102.
Quist TS, Givens DJ, Gurgel RK, Chamoun R, Shelton C. Hearing preservation after middle fossa vestibular schwannoma removal: are the results durable. Otolaryngol Head Neck Surg. 2015;152(4):706‐711. doi:10.1177/0194599814567874
Park HR, Jeong SS, Kim JH, et al. Long‐term outcome of unilateral acoustic neuromas with or without hearing loss: Over 10 years and beyond after gamma knife radiosurgery. J Korean Med Sci. 2023;38(40):e332. doi:10.3346/jkms.2023.38.e332
Chee GH, Nedzelski JM, Rowed D. Acoustic neuroma surgery: the results of long‐term hearing preservation. Otol Neurotol. 2003;24(4):672‐676. doi:10.1097/00129492-200307000-00023
Kirchmann M, Karnov K, Hansen S, Dethloff T, Stangerup SE, Caye‐Thomasen P. Ten‐year follow‐up on tumor growth and hearing in patients observed with an intracanalicular vestibular schwannoma. Neurosurgery. 2017;80(1):49‐56. doi:10.1227/NEU.0000000000001414
Balossier A, Tuleasca C, Delsanti C, et al. Long‐term hearing outcome after radiosurgery for vestibular schwannoma: a systematic review and meta‐analysis. Neurosurgery. 2023;92(6):1130‐1141. doi:10.1227/neu.0000000000002354
Coughlin AR, Willman TJ, Gubbels SP. Systematic review of hearing preservation after radiotherapy for vestibular schwannoma. Otol Neurotol. 2018;39(3):273‐283. doi:10.1097/MAO.0000000000001672
Turek G, Dzierzęcki S, Obierzyński P, Rogala A, Ząbek M, Ząbek M. Tumor control and hearing preservation after radiosurgery of intracanalicular vestibular schwannomas—systematic review. Wideochir Inne Tech Maloinwazyjne. 2022;17(3):450‐456. doi:10.5114/wiitm.2022.115169
Yang I, Aranda D, Han SJ, et al. Hearing preservation after stereotactic radiosurgery for vestibular schwannoma: a systematic review. J Clin Neurosci. 2009;16(6):742‐747. doi:10.1016/j.jocn.2008.09.023
Tsao MN, Sahgal A, Xu W, et al. Stereotactic radiosurgery for vestibular schwannoma: International Stereotactic Radiosurgery Society (ISRS) Practice Guideline. J Radiosurg SBRT. 2017;5(1):5‐24.
Watanabe S, Yamamoto M, Kawabe T, et al. Stereotactic radiosurgery for vestibular schwannomas: average 10‐year follow‐up results focusing on long‐term hearing preservation. J Neurosurg. 2016;125(suppl_1):64‐72. doi:10.3171/2016.7.GKS161494
Sughrue ME, Yang I, Aranda D, Kane AJ, Parsa AT. Hearing preservation rates after microsurgical resection of vestibular schwannoma. J Clin Neurosci. 2010;17(9):1126‐1129. doi:10.1016/j.jocn.2010.01.018
Ahsan SF, Huq F, Seidman M, Taylor A. Long‐term hearing preservation after resection of vestibular schwannoma: a systematic review and meta‐analysis. Otol Neurotol. 2017;38(10):1505‐1511. doi:10.1097/MAO.0000000000001560
Hunt AA, Cass ND, Coughlin A, Gubbels SP. Time‐based assessment of hearing preservation rates after microsurgical resection of vestibular schwannomas: a systematic review. Otol Neurotol. 2020;41(5):679‐685. doi:10.1097/MAO.0000000000002598
Golfinos JG, Hill TC, Rokosh R, et al. A matched cohort comparison of clinical outcomes following microsurgical resection or stereotactic radiosurgery for patients with small‐ and medium‐sized vestibular schwannomas. J Neurosurg. 2016;125(6):1472‐1482. doi:10.3171/2015.12.JNS151857
Kaylie DM, Horgan MJ, Delashaw JB, McMenomey SO. A meta‐analysis comparing outcomes of microsurgery and gamma knife radiosurgery. Laryngoscope. 2000;110(11):1850‐1856. doi:10.1097/00005537-200011000-00016
Maniakas A, Saliba I. Microsurgery versus stereotactic radiation for small vestibular schwannomas: a meta‐analysis of patients with more than 5 years' follow‐up. Otol Neurotol. 2012;33(9):1611‐1620. doi:10.1097/MAO.0b013e31826dbd02
Aman RA, Petonengan DAA, Hafif M, Santoso F. Hearing preservation, facial nerve dysfunction, and tumor control in small vestibular schwannoma: a systematic review of gamma knife radiosurgery versus microsurgery. J Clin Neurol. 2023;19(3):304. doi:10.3988/jcn.2022.0116
Hecht CS, Honrubia VF, Wiet RJ, Sims HS. Hearing preservation after acoustic neuroma resection with tumor size used as a clinical prognosticator. Laryngoscope. 1997;107(8):1122‐1126. doi:10.1097/00005537-199708000-00021
Satar B, Yetiser S, Özkaptan Y. Impact of tumor size on hearing outcome and facial function with the middle fossa approach for acoustic neuroma: a meta‐analytic study. Acta Otolaryngol. 2003;123(4):499‐505. doi:10.1080/00016480310000566a
Kanzaki J, Tos M, Sanna M, Moffat DA, Monsell EM, Berliner KI. New and modified reporting systems from the consensus meeting on systems for reporting results in vestibular schwannoma. Otol Neurotol. 2003;24(4):642‐648. doi:10.1097/00129492-200307000-00019
Sanna M, Khrais T, Piccirillo E, Russo A, Augurio A. Hearing preservation surgery in vestibular schwannoma: the hidden truth. Ann Otol Rhinol Laryngol. 2004;113(2):156‐163. doi:10.1177/000348940411300215
Meyer TA, Canty PA, Wilkinson EP, Hansen MR, Rubinstein JT, Gantz BJ. Small acoustic neuromas: Surgical outcomes versus observation or radiation. Otol Neurotol. 2006;27(3):380‐392. doi:10.1097/00129492-200604000-00015
Zanoletti E, Mazzoni A, Martini A, et al. Surgery of the lateral skull base: a 50‐year endeavour. Acta Otorhinolaryngol Ital. 2019;39(suppl 1):S1‐S146. doi:10.14639/0392-100X-suppl.1-39-2019
Kari E, Friedman RA. Hearing preservation: microsurgery. Curr Opin Otolaryngol Head Neck Surg. 2012;20(5):358‐366. doi:10.1097/MOO.0b013e3283579673
Chung WY, Liu KD, Shiau CY, et al. Gamma knife surgery for vestibular schwannoma: 10‐year experience of 195 cases. J Neurosurg. 2005;102(special_suppl):87‐97. doi:10.3171/sup.2005.102.s_supplement.0087
Hasegawa T, Kida Y, Kobayashi T, Yoshimoto M, Mori Y, Yoshida J. Long‐term outcomes in patients with vestibular schwannomas treated using gamma knife surgery: 10‐year follow up. J Neurosurg. 2005;102(1):10‐16. doi:10.3171/jns.2005.102.1.0010
Marston AP, Jacob JT, Carlson ML, Pollock BE, Driscoll CLW, Link MJ. Pretreatment growth rate as a predictor of tumor control following Gamma Knife radiosurgery for sporadic vestibular schwannoma. J Neurosurg. 2017;127(2):380‐387. doi:10.3171/2016.5.JNS153013
Hasegawa T, Kida Y, Kato T, Iizuka H, Yamamoto T. Factors associated with hearing preservation after Gamma Knife surgery for vestibular schwannomas in patients who retain serviceable hearing: clinical article. J Neurosurg. 2011;115(6):1078‐1086. doi:10.3171/2011.7.JNS11749
Kano H, Kondziolka D, Khan A, Flickinger JC, Lunsford LD. Predictors of hearing preservation after stereotactic radiosurgery for acoustic neuroma: clinical article. J Neurosurg. 2009;111(4):863‐873. doi:10.3171/2008.12.JNS08611